These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 25418272

  • 1. Meta-analysis of tumor necrosis factor inhibitors and glucocorticoids on bone density in rheumatoid arthritis and ankylosing spondylitis trials.
    Siu S, Haraoui B, Bissonnette R, Bessette L, Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, Fleming P, Kraft J, Lynde C, Gulliver W, Keeling S, Dutz J, Pope JE.
    Arthritis Care Res (Hoboken); 2015 May; 67(6):754-64. PubMed ID: 25418272
    [Abstract] [Full Text] [Related]

  • 2. Use of bisphosphonate might be important to improve bone mineral density in patients with rheumatoid arthritis even under tight control: the TOMORROW study.
    Tada M, Inui K, Sugioka Y, Mamoto K, Okano T, Anno S, Koike T.
    Rheumatol Int; 2017 Jun; 37(6):999-1005. PubMed ID: 28405825
    [Abstract] [Full Text] [Related]

  • 3. Are changes in bone mineral density different between groups of early rheumatoid arthritis patients treated according to a tight control strategy with or without prednisone if osteoporosis prophylaxis is applied?
    van der Goes MC, Jacobs JW, Jurgens MS, Bakker MF, van der Veen MJ, van der Werf JH, Welsing PM, Bijlsma JW.
    Osteoporos Int; 2013 Apr; 24(4):1429-36. PubMed ID: 23011680
    [Abstract] [Full Text] [Related]

  • 4. Effect of TNF-alpha inhibitor treatment on bone mineral density in patients with ankylosing spondylitis: a systematic review and meta-analysis.
    Haroon NN, Sriganthan J, Al Ghanim N, Inman RD, Cheung AM.
    Semin Arthritis Rheum; 2014 Oct; 44(2):155-61. PubMed ID: 24909809
    [Abstract] [Full Text] [Related]

  • 5. The effect of glucocorticoids on bone mineral density in patients with rheumatoid arthritis: A systematic review and meta-analysis of randomized, controlled trials.
    Blavnsfeldt AG, de Thurah A, Thomsen MD, Tarp S, Langdahl B, Hauge EM.
    Bone; 2018 Sep; 114():172-180. PubMed ID: 29913256
    [Abstract] [Full Text] [Related]

  • 6. Different Effects of Biologics on Systemic Bone Loss Protection in Rheumatoid Arthritis: An Interim Analysis of a Three-Year Longitudinal Cohort Study.
    Chen MH, Yu SF, Chen JF, Chen WS, Liou TL, Chou CT, Hsu CY, Lai HM, Chen YC, Tsai CY, Cheng TT.
    Front Immunol; 2021 Sep; 12():783030. PubMed ID: 34987510
    [Abstract] [Full Text] [Related]

  • 7. Effect of tumor necrosis factor alpha inhibition on bone density and turnover markers in patients with rheumatoid arthritis and spondyloarthropathy.
    Barnabe C, Hanley DA.
    Semin Arthritis Rheum; 2009 Oct; 39(2):116-22. PubMed ID: 18585759
    [Abstract] [Full Text] [Related]

  • 8. Periarticular bone gain at proximal interphalangeal joints and changes in bone turnover markers in response to tumor necrosis factor inhibitors in rheumatoid and psoriatic arthritis.
    Szentpetery A, McKenna MJ, Murray BF, Ng CT, Brady JJ, Morrin M, Radovits B, Veale DJ, Fitzgerald O.
    J Rheumatol; 2013 May; 40(5):653-62. PubMed ID: 23457381
    [Abstract] [Full Text] [Related]

  • 9. The limited effects of anti-tumor necrosis factor blockade on bone health in patients with rheumatoid arthritis under the use of glucocorticoid.
    Okano T, Koike T, Tada M, Sugioka Y, Mamoto K, Wakitani S, Nakamura H.
    J Bone Miner Metab; 2014 Sep; 32(5):593-600. PubMed ID: 24233123
    [Abstract] [Full Text] [Related]

  • 10. Maternal and Fetal Outcomes in a Cohort of Patients Exposed to Tumor Necrosis Factor Inhibitors throughout Pregnancy.
    Genest G, Spitzer KA, Laskin CA.
    J Rheumatol; 2018 Aug; 45(8):1109-1115. PubMed ID: 29961692
    [Abstract] [Full Text] [Related]

  • 11. Effect of TNF inhibitors on bone mineral density in rheumatoid arthritis patients receiving bisphosphonate: a retrospective cohort study.
    Lee JS, Lim DH, Oh JS, Kim YG, Lee CK, Yoo B, Hong S.
    Rheumatol Int; 2020 Mar; 40(3):481-487. PubMed ID: 31414225
    [Abstract] [Full Text] [Related]

  • 12. Abatacept might increase bone mineral density at femoral neck for patients with rheumatoid arthritis in clinical practice: AIRTIGHT study.
    Tada M, Inui K, Sugioka Y, Mamoto K, Okano T, Koike T.
    Rheumatol Int; 2018 May; 38(5):777-784. PubMed ID: 29294175
    [Abstract] [Full Text] [Related]

  • 13. Comparative Persistence of Methotrexate and Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis.
    George MD, Baker JF, Ogdie A.
    J Rheumatol; 2020 Jun 01; 47(6):826-834. PubMed ID: 31474599
    [Abstract] [Full Text] [Related]

  • 14. Real-life 10-year retention rate of first-line anti-TNF drugs for inflammatory arthritides in adult- and juvenile-onset populations: similarities and differences.
    Favalli EG, Pontikaki I, Becciolini A, Biggioggero M, Ughi N, Romano M, Crotti C, Gattinara M, Gerloni V, Marchesoni A, Meroni PL.
    Clin Rheumatol; 2017 Aug 01; 36(8):1747-1755. PubMed ID: 28597133
    [Abstract] [Full Text] [Related]

  • 15. Long-Term Treatment With TNF-Alpha Inhibitors Improves Bone Mineral Density But Not Vertebral Fracture Progression in Ankylosing Spondylitis.
    Beek KJ, Rusman T, van der Weijden MAC, Lems WF, van Denderen JC, Konsta M, Visman I, Nurmohamed MT, van der Horst-Bruinsma IE.
    J Bone Miner Res; 2019 Jun 01; 34(6):1041-1048. PubMed ID: 30690799
    [Abstract] [Full Text] [Related]

  • 16. Changes in bone mineral density during long-term treatment with adalimumab in patients with rheumatoid arthritis: a cohort study.
    Krieckaert CL, Nurmohamed MT, Wolbink G, Lems WF.
    Rheumatology (Oxford); 2013 Mar 01; 52(3):547-53. PubMed ID: 23221326
    [Abstract] [Full Text] [Related]

  • 17. Potential alleviation of bone mineral density loss with Janus kinase inhibitors in rheumatoid arthritis.
    Chen YW, Chen HH, Huang WN, Chen JP, Chen YH, Chen YM.
    Clin Rheumatol; 2024 Jan 01; 43(1):117-128. PubMed ID: 37658935
    [Abstract] [Full Text] [Related]

  • 18. Disease activity and disability but probably not glucocorticoid treatment predicts loss in bone mineral density in women with early rheumatoid arthritis.
    Book C, Karlsson M, Akesson K, Jacobsson L.
    Scand J Rheumatol; 2008 Jan 01; 37(4):248-54. PubMed ID: 18612924
    [Abstract] [Full Text] [Related]

  • 19. Changes in bone mineral density in patients with recent onset, active rheumatoid arthritis.
    Güler-Yüksel M, Bijsterbosch J, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Hulsmans HM, de Beus WM, Han KH, Breedveld FC, Dijkmans BA, Allaart CF, Lems WF.
    Ann Rheum Dis; 2008 Jun 01; 67(6):823-8. PubMed ID: 17644545
    [Abstract] [Full Text] [Related]

  • 20. Effects of glucocorticoids on osteoporosis in rheumatoid arthritis: a systematic review and meta-analysis.
    Wang Y, Zhao R, Gu Z, Dong C, Guo G, Li L.
    Osteoporos Int; 2020 Aug 01; 31(8):1401-1409. PubMed ID: 32291467
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.